All Stories

  1. Quantification of Zika virus using a colloidal gold nanoparticle-based immunosensor and Fourier-transform infrared spectroscopy
  2. Development and validation of a dynamic light scattering-based method for viral quantification: A straightforward protocol for a demanding task
  3. Unlocking the Gate: Keys to Understanding Zika Virus Interactions with Human Cell Receptors
  4. Step-by-step protocol: IAV titration by Dynamic Light Scattering v1
  5. Role of the NLRP3 inflammasome in the immunopathogenesis of flaviviruses
  6. Advances in the Elimination of Viral Hepatitis in Mexico: A Local Perspective on the Global Initiative
  7. Baloxavir Resistance Markers in Influenza A and B Viruses in the Americas
  8. Non-Analog Compounds to Sialic Acid as Inhibitors of Influenza Virus Neuraminidase: An Underexplored Approach for Novel Antivirals―Systematic Review
  9. Detection of Zika Virus by the Development of a Colloidal Gold Nanoparticle-Based Immunosensor
  10. Comparative Review of the State of the Art in Research on the Porcine Epidemic Diarrhea Virus and SARS-CoV-2, Scope of Knowledge between Coronaviruses
  11. Hepatitis B Virus and Hepatocellular Cancer: Molecular Mechanisms and Breakthroughs in Therapeutic Approaches
  12. Hepatitis C Virus and Hepatocellular Cancer: Molecular Mechanisms and Advancements in Treatment
  13. Antiviral resistance in influenza viruses
  14. Age and Comorbidities as Risk Factors for Severe COVID-19 in Mexico, before, during and after Massive Vaccination
  15. Donated Blood Screening for HIV, HCV and HBV by ID-NAT and the Residual Risk of Iatrogenic Transmission in a Tertiary Care Hospital Blood Bank in Puebla, Mexico
  16. Chronic Comorbidities in Middle Aged Patients Contribute to Ineffective Emergency Hematopoiesis in Covid-19 Fatal Outcomes
  17. SARS-CoV-2: basic concepts, origin and treatment advances
  18. Response to Article “Serum Levels of Galectin-9 are Increased in Cervical Cancer Patients and are Higher in Advanced Clinical Stages” [Response to Letter]
  19. Serum Levels of Galectin-9 are Increased in Cervical Cancer Patients and are Higher in Advanced Clinical Stages
  20. Decrease in COVID-19 adverse outcomes in adults during the Delta and Omicron SARS-CoV-2 waves, after vaccination in Mexico
  21. In silicotesting of flavonoids as potential inhibitors of protease and helicase domains of dengue and Zika viruses
  22. Neuropathological Aspects of SARS-CoV-2 Infection: Significance for Both Alzheimer’s and Parkinson’s Disease
  23. Predicted 3D model of the M protein of Porcine Epidemic Diarrhea Virus and analysis of its immunogenic potential
  24. Salud porcina: historia, retos y perspectivas
  25. Effectiveness, tolerability and safety of Direct Acting Antivirals in Mexican individuals with Hepatitis C virus genotype-1 and previous pegylated interferon and ribavirin therapy
  26. Serum Th17 and TNF-α distinguish between patients with occult hepatitis B infection, chronic hepatitis B infection and healthy individuals
  27. Estudio de casos confirmados de brucelosis humana en Puebla, México
  28. A comprehensive update of the status of hepatitis C virus (HCV) infection in Mexico—A systematic review and meta-analysis (2008–2019)
  29. The role of metabolic comorbidity in COVID-19 mortality of middle-aged adults. The case of Mexico
  30. Glycogene expression profiles from a HaCaT cell line stably transfected with HPV16 E5 oncogene
  31. Immunoinformatics approach for predicting epitopes in HN and F proteins of Porcine rubulavirus
  32. Five Novel Non-Sialic Acid-Like Scaffolds Inhibit In Vitro H1N1 and H5N2 Neuraminidase Activity of Influenza a Virus
  33. Primary Dengue Infection in Patients Requiring Hospitalization During an Outbreak in a Low Incidence Mexican Region
  34. Identification and characterization of the V3 promoter of the ST3GAL4 gene
  35. Differential Transcription of SOCS5 and SOCS7 in Multiple Sclerosis Patients Treated with Interferon Beta or Glatiramer Acetate
  36. Antiviral and immunomodulatory effects of polyphenols on macrophages infected with dengue virus serotypes 2 and 3 enhanced or not with antibodies
  37. Effectiveness of PCR primers for the detection of occult hepatitis B virus infection in Mexican patients
  38. Drug resistance in influenza viruses from Mexico
  39. Glycogene expression profiles based on microarray data from cervical carcinoma HeLa cells with partially silenced E6 and E7 HPV oncogenes
  40. Diabetic ketoacidosis complicated by supraventricular tachycardia in a young adult: a case report
  41. Expression analysis of ST3GAL4 transcripts in cervical cancer cells
  42. Taraxacum officinale and Urtica dioica extracts inhibit dengue virus serotype 2 replication in vitro
  43. Neuraminidase activity of blue eye disease porcine rubulavirus: Specificity, affinity and inhibition studies
  44. Polymorphisms in the hepatitis C virus core and its association with development of hepatocellular carcinoma
  45. Heterologous Expression of Laccase (LACP83) of Pleurotus ostreatus
  46. Hepatic mobilization of zinc after an experimental surgery, and its relationship with inflammatory cytokines release, and expression of metallothionein and Zip14 transporter
  47. Prevalence of Serologic Hepatitis B Markers in Blood Donors From Puebla, Mexico: The Association of Relatively High Levels of Anti-Core Antibodies With the Detection of Surface Antigen and Genomic DNA
  48. Hepatitis B surface antibodies in medical students from a public university in Puebla, Mexico
  49. Production of an enzymatically active and immunogenic form of ectodomain of Porcine rubulavirus hemagglutinin-neuraminidase in the yeast Pichia pastoris
  50. Upregulation of the Suppressors of Cytokine Signaling 1 and 3 Is Associated with Arrest of Phosphorylated-STAT1 Nuclear Importation and Reduced Innate Response in Denguevirus-Infected Macrophages
  51. Interferon lambda inhibits dengue virus replication in epithelial cells
  52. Chemoenzymatic Syntheses of Sialylated Oligosaccharides Containing C5-Modified Neuraminic Acids for Dual Inhibition of Hemagglutinins and Neuraminidases
  53. Human papillomavirus infections in Mexican women with normal cytology, precancerous lesions, and cervical cancer: Type-specific prevalence and HPV coinfections
  54. Quantitative analysis of the suppressors of cytokine signaling 1 and 3 in peripheral blood leukocytes of patients with multiple sclerosis
  55. Transfection of influenza A virus nuclear export protein induces the expression of tumor necrosis factor alpha
  56. Detection of hepatitis C virus RNA in saliva of patients with active infection not associated with periodontal or liver disease severity
  57. Promoter Polymorphisms of ST3GAL4 and ST6GAL1 Genes and Associations with Risk of Premalignant and Malignant Lesions of the Cervix
  58. Sialyl Lewis x expression in cervical scrapes of premalignant lesions
  59. Characterization of P1 promoter activity of the β-galactoside α2,6sialyltransferase I gene (siat 1) in cervical and hepatic cancer cell lines
  60. Modulation of apoptosis by V protein mumps virus
  61. Los problemas de la nomenclatura de virus
  62. Interaction of mumps virus V protein variants with STAT1-STAT2 heterodimer: experimental and theoretical studies
  63. Human papillomavirus infection in women from Tlaxcala, Mexico
  64. Increased expression of sialic acid in cervical biopsies with squamous intraepithelial lesions
  65. Hepatitis C virus infection in blood donors from the state of Puebla, Mexico
  66. Quantitative analysis of interferon alpha receptor subunit 1 and suppressor of cytokine signaling 1 gene transcription in blood cells of patients with chronic hepatitis C
  67. Prevalence of human papillomavirus genotypes in women from a rural region of Puebla, Mexico
  68. Structure-function analysis of two variants of mumps virus hemagglutinin-neuraminidase protein
  69. Molecular characterization of the hemagglutinin-neuraminidase gene of porcine rubulavirus isolates associated with neurological disorders in fattening and adult pigs
  70. Prevalence of hepatitis C virus in the Mexican population: A systematic review
  71. Biochemical characterization and structural prediction of a novel cytosolic leucyl aminopeptidase of the M17 family from Schizosaccharomyces pombe
  72. Differential sensitivity to interferon influences the replication and transcription of Urabe AM9 mumps virus variants in nerve cells
  73. Amino acid change 335 E to K affects the sialic-acid-binding and neuraminidase activities of Urabe AM9 mumps virus hemagglutinin–neuraminidase glycoprotein
  74. Two clones obtained from Urabe AM9 mumps virus vaccine differ in their replicative efficiency in neuroblastoma cells
  75. Purification of the Porcine rubulavirus attachment protein by liquid isoelectric focusing
  76. Purification and characterization of the Hemagglutinin-Neuraminidase of porcine rubulavirus LPMV